FDA nod for Boehringer/Lilly’s once-daily diabetes combo by Selina McKee | Dec 13, 2016 | News | 0 US regulators have cleared the use of a once-daily formulation of Boehringer Ingelheim and Eli Lilly’s diabetes drug Synjardy. Read More
US regulators expand use of Boehringer/Lilly’s diabetes drug by Selina McKee | Jul 20, 2016 | News | 0 US regulators have expanded the scope of Boehringer Ingelheim and Eli Lilly’s Synjardy to include treatment-naïve adults with type II diabetes. Read More